ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Emergency Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,727Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 40

$857K Total Retail Price of All Prescriptions

Rank: 1 out of 40

971 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 971 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

12% of this provider’s 971 patients filled at least one prescription for a schedule three drug, compared to an average of 23%.

Risky Drugs to Seniors

2% of this provider’s 13,621 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 15%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $39 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 4.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LISINOPRIL 770 611 1 2
LEVOTHYROXINE SODIUM 629 537 2 3
OMEPRAZOLE 534 420 3 5
FUROSEMIDE 480 425 4 4
METFORMIN HCL 431 342 5 6
PRAVASTATIN SODIUM 424 328 6 11
GABAPENTIN 376 289 7 10
TRAMADOL HCL 372 291 8 9
AMLODIPINE BESYLATE 323 264 9 12
SIMVASTATIN 322 270 10 7
HYDROCHLOROTHIAZIDE 313 273 11 17
WARFARIN SODIUM 308 260 12 19
LOVASTATIN 277 238 13 22
METOPROLOL TARTRATE 276 253 14 15
CARVEDILOL 258 218 15 24
SERTRALINE HCL 246 204 16 25
POTASSIUM CHLORIDE 246 223 16 25
DONEPEZIL HCL 229 223 18 16
PREDNISONE 228 182 19 14
CIPROFLOXACIN HCL 226 197 20 21
HYDROCODONE-ACETAMINOPHEN 217 147 S3 21 1
CITALOPRAM HBR 207 170 22 23
METOPROLOL SUCCINATE 204 163 23 27
NAPROXEN 184 136 24 28
LOSARTAN POTASSIUM 183 162 25 29
CLOPIDOGREL 178 159 26 30
LANTUS 174 147 27 31
ALENDRONATE SODIUM 163 132 28 32
TAMSULOSIN HCL 144 118 29 33
ATENOLOL 143 113 30 34
ZOLPIDEM TARTRATE 142 117 31 35
GLIPIZIDE 125 114 32 37
CLONIDINE HCL 125 105 32 37
ATORVASTATIN CALCIUM 124 113 34 39
AZITHROMYCIN 114 88 35 18
NIFEDIPINE ER 111 101 36 40
KLOR-CON M20 109 76 37 41
GLIPIZIDE ER 101 81 38 42
PLAVIX 101 90 38 42
ISOSORBIDE MONONITRATE ER 96 87 40 44
OXYCODONE-ACETAMINOPHEN 94 50 S2 41 13
DIGOXIN 93 93 42 45
FLUTICASONE PROPIONATE 92 65 43 46
DOXAZOSIN MESYLATE 90 77 44 47
CYCLOBENZAPRINE HCL 87 47 R 45 48
LISINOPRIL-HYDROCHLOROTHIAZIDE 86 55 46 49
PROMETHAZINE HCL 86 59 R 46 49
RANITIDINE HCL 85 76 48 51
MELOXICAM 85 66 48 51
OXYBUTYNIN CHLORIDE 84 81 50 53
RAMIPRIL 82 82 51 54
MIRTAZAPINE 81 76 52 55
CRESTOR 76 59 53 56
TRAZODONE HCL 75 53 54 57
INSULIN SYRINGE 72 64 55 58
TERAZOSIN HCL 72 65 55 58
RISPERIDONE 71 61 57 60
METHYLPREDNISOLONE 70 51 58 61
FLUOXETINE HCL 67 40 59 62
NAMENDA 67 67 59 36
SPIRIVA 65 58 61 63
DILTIAZEM HCL 65 60 61 63
SYMBICORT 65 56 61 63
ALLOPURINOL 64 62 64 66
DILTIAZEM 24HR CD 61 53 65 68
BENICAR 61 49 65 68
SPIRONOLACTONE 61 43 65 68
ZETIA 60 49 68 71
ADVAIR DISKUS 60 58 68 71
IBUPROFEN 58 31 70 20
CYMBALTA 58 34 70 73
NOVOLIN R 54 49 72 74
DIOVAN 52 52 73 75
KLOR-CON M10 52 39 73 75
NOVOLOG MIX 70-30 51 41 75 77
METOCLOPRAMIDE HCL 50 36 76 78
IPRATROPIUM-ALBUTEROL 50 49 76 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 6, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.